FireEye (FEYE) Stock Upgraded - Price Target $42

FireEye (FEYE) Upgraded - 2014 Price Target $42 - @stockstobuy -

FireEye (FEYE) stock was upgraded by Goldman Sachs today with a 2014 price target of $42.  FireEye (FEYE) has been struggling recently after shares crashed due to the IPO lock up expiration.  FEYE hit a high of $97.35 in early 2014 and then dropped to $25.58 months later.  Goldman Sachs believes FireEye is positioned to be the leader in Cyber-Security as we head into 2015.  FEYE is up 4.6% to $35.47 in pre market trading.

Check out more hot stocks in 2014 - Stock Gainers 2014 - Penny Stocks Gainers 2014

Plug Power (PLUG) Stock Upgraded - 2014 Price Target $8

Plug Power (PLUG) Upgraded with 2014 Price Target $8 - @stockstobuy -

Plug Power (PLUG) received an upgrade last night from FBR Capital which is causing shares to rise 10% in pre market to $4.60.  PLUG was labeled an outperform with an $8 price target.  The firm sees multiple catalysts ahead for the company.

Plug Power (PLUG) rallied from $3-$12 earlier this year and entered bubble territory before crashing back to earth a few days after.  PLUG will have long term resistance up at $5.25 before the ball gets rolling.

Check out more hot stocks in 2014 - Stock Gainers 2014 - Penny Stocks Gainers 2014

Intercept Pharmaceuticals (ICPT) Stock Analysis 1/13/14 January 13, 2014

Intercept Pharmaceuticals (ICPT) Stock Analysis 1/13/14 January 13, 2014 -

 Follow @stockstobuy 

Intercept Pharmaceuticals (ICPT) surged again on Friday after the company reported strong liver disease drug data last week.  ICPT stock is now one of the Top Stocks in 2014 with a gain of over 550%.

Intercept Pharmaceuticals (ICPT) dropped into the close on Friday and again in after hours trading.  Shares closed the regular session at $446 and closed after hours at $418.50.  ICPT will have support at $387 as well as $373.  A break below $373 could set up a move to $340-$350 but then produce a bounce.  We will be watching it in the Stock Picks Group.

Also see - Top Stocks 2014 - Top Stock Gainers 2014

Intercept Pharmaceuticals (ICPT) Price Target - $872 by Bank of America

Intercept Pharmaceuticals (ICPT) 2014 Price Target - $872 by Bank of America -

 Follow @stockstobuy 

Intercept Pharmaceuticals (ICPT) stopped a drug trial early recently and the stock is on fire.  This morning, ICPT received multiple price target upgrades and Bank of America believe shares could eventually hit $872 - http://www.stockstobuy.org/forum/topics/intercept-pharmaceuticals-icpt-top-stocks-in-2014

Intercept Pharmaceuticals (ICPT) is now one of the top stocks in 2014 and will be volatile for months to come.  We will be watching it in the Stock Picks Group.

Also see - Top Stocks 2014 - Top Stock Gainers 2014